English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Merck
Carol Ostrow
| May 16, 2018
FDA accepts two new drug applications for Merck HIV-1 therapy
Marian Johns
| Jan 17, 2018
FDA approves Lynparza as first PARP Inhibitor for treating metastatic breast cancer
Carol Ostrow
| Jan 7, 2018
Merck, Pfizer Type 2 diabetes treatments gain FDA approval
Carol Ostrow
| Oct 15, 2017
Merck KGaA aims raise awareness, boost support for unpaid caregivers
Carol Ostrow
| Oct 1, 2017
Merck to host meeting on third-quarter performance
Russell Boniface
| Sep 13, 2017
Merck's Keytruda wins European approval as bladder cancer treatment
Robert Hadley
| Jun 16, 2017
Merck’s Keytruda shown effective in treating aggressive form of breast cancer
Tabitha Fleming
| Jun 2, 2017
Merck's Keytruda approved for treating Hodgkin's lymphoma in Europe
Trending
+
Pharmaceuticals
Patient Daily
| Oct 22, 2024
Bristol Myers Squibb funds $2.25M cervical cancer project in Malawi
+
Pharmaceuticals
Patient Daily
| Oct 21, 2024
Baylor professors Bottazzi and Davis elected to National Academy of Medicine
+
Pharmaceuticals
Patient Daily
| Oct 22, 2024
American Lung Association welcomes three leaders to Georgia board
+
Pharmaceuticals
Patient Daily
| Oct 24, 2024
Dr. Huda Zoghbi honored by American Academy for her contributions to science
1
2
»
Last »